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SUMMARY. A selective and sensitive liquid chromatography-mass spectrometry (LC–MS) method for de-
termination of ondansetron in rat plasma was developed and validated. After addition of midazolam as in-
ternal standard (IS), protein precipitation by acetonitrile was used as sample preparation, and chromatog-
raphy involved Agilent SB-C18 column (2.1 x 150 mm, 5 μm) using 0.1 % formic acid in water and ace-
tonitrile as a mobile phase with gradient elution. Detection involved positive ion mode electrospray ioniza-
tion (ESI), and multiple reaction monitoring (MRM) mode was used for quantification of target fragment
ions m/z 294.0→169.7 for ondansetron and m/z 326.0→291.0 for midazolam (internal standard, IS). The
assay was linear over the range of 5–1000 ng/mL for ondansetron, with a lower limit of quantitation
(LLOQ) of 5 ng/mL for ondansetron. Intra- and inter-day precisions were less than 14 % and the accura-
cies were in the range of 94.7-113.5 % for ondansetron. This developed method was successfully applied
for the determination of ondansetron in rat plasma for pharmacokinetic study.
